|
|
|
Volumn 24, Issue 2 Suppl 7, 1997, Pages
|
|
Single-agent gemcitabine in non-small cell lung cancer: the French experience.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC ANTIMETABOLITE;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
GEMCITABINE;
RIBONUCLEOTIDE REDUCTASE;
ARTICLE;
CLINICAL TRIAL;
DRUG ANTAGONISM;
FEMALE;
FRANCE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MALE;
MIDDLE AGED;
MORTALITY;
MULTICENTER STUDY;
PHASE 2 CLINICAL TRIAL;
SURVIVAL RATE;
ANTIMETABOLITES, ANTINEOPLASTIC;
CARCINOMA, NON-SMALL-CELL LUNG;
DEOXYCYTIDINE;
FEMALE;
FRANCE;
HUMANS;
INFUSIONS, INTRAVENOUS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
RIBONUCLEOTIDE REDUCTASES;
SURVIVAL RATE;
|
|
EID: 0031112604
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
